News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
705,231 Results
Type
Article (54006)
Company Profile (246)
Press Release (650979)
Multimedia
Podcasts (93)
Webinars (13)
Section
Business (197749)
Career Advice (2861)
Deals (35336)
Drug Delivery (123)
Drug Development (80224)
Employer Resources (187)
FDA (16391)
Job Trends (15074)
News (338263)
Policy (32622)
Tag
Academia (2874)
Academic (2)
Accelerated approval (5)
Adcomms (27)
Allergies (94)
Alliances (50821)
ALS (104)
Alzheimer's disease (1470)
Antibody-drug conjugate (ADC) (156)
Approvals (16355)
Artificial intelligence (311)
Autoimmune disease (25)
Automation (17)
Bankruptcy (353)
Best Places to Work (11802)
BIOSECURE Act (20)
Biosimilars (112)
Biotechnology (174)
Bladder cancer (87)
Brain cancer (29)
Breast cancer (297)
Cancer (2395)
Cardiovascular disease (204)
Career advice (2422)
Career pathing (34)
CAR-T (177)
Cell therapy (480)
Cervical cancer (20)
Clinical research (64921)
Collaboration (914)
Company closure (2)
Compensation (445)
Complete response letters (26)
COVID-19 (2729)
CRISPR (50)
C-suite (273)
Cystic fibrosis (103)
Data (2374)
Decentralized trials (2)
Denatured (28)
Depression (56)
Diabetes (285)
Diagnostics (6783)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (47)
Drug discovery (130)
Drug pricing (120)
Drug shortages (30)
Duchenne muscular dystrophy (101)
Earnings (76398)
Editorial (46)
Employer branding (25)
Employer resources (161)
Events (108957)
Executive appointments (788)
FDA (17792)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (818)
Gene editing (122)
Generative AI (28)
Gene therapy (354)
GLP-1 (809)
Government (4593)
Grass and pollen (5)
Guidances (169)
Healthcare (19311)
Huntington's disease (26)
IgA nephropathy (31)
Immunology and inflammation (148)
Indications (30)
Infectious disease (2887)
Inflammatory bowel disease (150)
Inflation Reduction Act (12)
Influenza (55)
Intellectual property (103)
Interviews (564)
IPO (16346)
IRA (49)
Job creations (3691)
Job search strategy (1998)
Kidney cancer (11)
Labor market (41)
Layoffs (516)
Leadership (24)
Legal (7870)
Liver cancer (77)
Lung cancer (341)
Lymphoma (157)
Machine learning (9)
Management (62)
Manufacturing (348)
MASH (86)
Medical device (14023)
Medtech (14028)
Mergers & acquisitions (19586)
Metabolic disorders (767)
Multiple sclerosis (87)
NASH (23)
Neurodegenerative disease (117)
Neuropsychiatric disorders (31)
Neuroscience (2088)
NextGen: Class of 2025 (6836)
Non-profit (4601)
Now hiring (41)
Obesity (405)
Opinion (260)
Ovarian cancer (82)
Pain (103)
Pancreatic cancer (88)
Parkinson's disease (164)
Partnered (20)
Patents (255)
Patient recruitment (117)
Peanut (49)
People (59687)
Pharmaceutical (51)
Pharmacy benefit managers (18)
Phase I (20169)
Phase II (28471)
Phase III (21589)
Pipeline (1468)
Policy (169)
Postmarket research (2606)
Preclinical (8785)
Press Release (72)
Prostate cancer (111)
Psychedelics (38)
Radiopharmaceuticals (255)
Rare diseases (418)
Real estate (5983)
Recruiting (73)
Regulatory (22419)
Reports (52)
Research institute (2515)
Resumes & cover letters (440)
Rett syndrome (6)
RNA editing (4)
RSV (48)
Schizophrenia (82)
Series A (144)
Series B (94)
Service/supplier (12)
Sickle cell disease (58)
Special edition (16)
Spinal muscular atrophy (156)
Sponsored (31)
Startups (3789)
State (2)
Stomach cancer (15)
Supply chain (69)
Tariffs (49)
The Weekly (63)
Vaccines (751)
Venture capitalists (43)
Weight loss (278)
Women's health (31)
Worklife (20)
Date
Today (197)
Last 7 days (911)
Last 30 days (3405)
Last 365 days (32760)
2025 (12317)
2024 (35640)
2023 (40449)
2022 (51580)
2021 (56087)
2020 (54725)
2019 (48134)
2018 (36484)
2017 (33672)
2016 (33083)
2015 (38705)
2014 (30855)
2013 (26186)
2012 (28265)
2011 (28978)
2010 (27294)
Location
Africa (921)
Alabama (54)
Alaska (7)
Arizona (222)
Arkansas (13)
Asia (41682)
Australia (7771)
California (6301)
Canada (2066)
China (551)
Colorado (272)
Connecticut (284)
Delaware (159)
Europe (94500)
Florida (958)
Georgia (216)
Hawaii (1)
Idaho (60)
Illinois (565)
India (28)
Indiana (328)
Iowa (10)
Japan (177)
Kansas (104)
Kentucky (22)
Louisiana (12)
Maine (68)
Maryland (945)
Massachusetts (4727)
Michigan (246)
Minnesota (412)
Mississippi (2)
Missouri (89)
Montana (30)
Nebraska (24)
Nevada (70)
New Hampshire (70)
New Jersey (1808)
New Mexico (31)
New York (1804)
North Carolina (1034)
North Dakota (9)
Northern California (2777)
Ohio (215)
Oklahoma (14)
Oregon (35)
Pennsylvania (1373)
Puerto Rico (13)
Rhode Island (33)
South America (1255)
South Carolina (25)
South Dakota (1)
Southern California (2356)
Tennessee (99)
Texas (935)
United States (23987)
Utah (195)
Virginia (159)
Washington D.C. (66)
Washington State (585)
West Virginia (3)
Wisconsin (67)
705,231 Results for "secure point technologies formerly known as implant sciences corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Bay
Science Corporation Acquires Pixium’s PRIMA Retinal Implant, Extending and Diversifying Its Commitment to Vision Restoration Through Brain-Computer Interface Technology
Science Corporation has acquired the IP and related assets for the PRIMA retinal implant.
April 25, 2024
·
3 min read
Business
New Jersey’s Life Sciences Scene Continues Expanding Beyond Big Pharma
Known as the home of big-name companies including Johnson & Johnson, New Jersey has become a destination for more and more small and midsize life sciences businesses. Choose New Jersey, Grace Therapeutics and Onyx Equities executives discuss the state’s life sciences scene.
April 10, 2025
·
6 min read
·
Angela Gabriel
Press Releases
Averna Therapeutics, formerly known as Exsilio Therapeutics, Appoints Thomas M. Barnes, Ph.D., as Chief Executive Officer
January 27, 2025
·
3 min read
Press Releases
AVAVA™ Receives FDA Clearance for Revolutionary Acne Scar Treatment using Focal Point Technology™
April 22, 2025
·
3 min read
Policy
Zomedica Expands Market Opportunity for the TRUFORMA Point-of-Care Diagnostic Platform by Securing CE Mark
Zomedica Corp. announced it has secured the CE mark for its proprietary point-of-care TRUFORMA Bulk Acoustic Wave diagnostic platform.
June 25, 2024
·
6 min read
Press Releases
Maxwell Biosciences Secures US Military Agreement to Research Scientific Aspects of Claromer Technology
U.S. Army Institute of Surgical Research to conduct key studies intended to further our knowledge of the effects of Claromer technology
March 5, 2025
·
2 min read
Sensorion Announces Upcoming Presentation of Promising SENS-401 Results at the Next International Conference on Cochlear Implants and Other Implantable Technologies
Sensorion announces that promising new data and analysis results from the SENS-401 following cochlear implantation Phase 2a clinical study will be presented at the 17th International Conference on Cochlear Implants and Other Implantable Technologies taking place on July 10-13, 2024, in Vancouver, Canada.
June 20, 2024
·
5 min read
Press Releases
Silo Pharma’s SP-26 Ketamine Implant Meets All Endpoints in Fibromyalgia Study
May 1, 2025
·
4 min read
Breast cancer
AstraZeneca, Daiichi Sankyo’s ADC Wins First Approval Despite Mixed Data
Datroway, formerly known as Dato-DXd, significantly improved median progression-free survival in a Phase III study but failed to do so for overall survival.
January 21, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Envoy Medical Reports Fourth Quarter and Full Year 2024 Financial Results
Company Provides Corporate Update that Includes Information on its Progress Enrolling Subjects in its Pivotal Clinical Study for Breakthrough Device, the Fully Implanted Acclaim® Cochlear Implant
March 31, 2025
·
15 min read
1 of 70,524
Next
